2021 March - 3 articles
Type 2 Diabetes (T2D) is the foremost cause of general mortality in Mexico. Mexico City, one of the most populated cities in the developing world, faces complex challenges to provide adequate health care to its more than 20 million inhabitants. This high concentration of population has placed the city among the top five cities with the highest diabetes mortality rates in the country.
Early detection and treatment of T2D is an important step toward keeping people with diabetes healthy and enhancing length and quality of life. Thus, in this study, we aimed to describe diabetes awareness, treatment targets, and treatment outcomes among Mexico City residents, as well as the inequalities in these outcomes, in order to provide evidence to better target interventions. View this paper
Diabetic kidney disease (DKD) is a global epidemic leading to end-stage renal disease (ESRD) and susceptibility to cardiovascular disease, with few therapeutic interventions. A hallmark of DKD is the activation of the renin-angiotensin-aldosterone sy...
Early diagnosis and control of diabetes can reduce premature mortality and disability. We described the diabetes prevalence, awareness, treatment, and control in Mexico City. Data came from the Mexico City Representative Diabetes Survey, conducted be...
When societies went into the COVID-19 lockdown, the conditions under which people with diabetes managed their illness dramatically changed. The present study explores experiences of everyday life during the COVID-19 lockdown among people with diabete...
Get Alerted
Add your email address to receive forthcoming issues of this journal.
